[1]
al_talkani, ahmed F. and H. Kathem, S. 2019. The Prevalence of UGT1A1*93 and ABCC5 Polymorphisms in Cancer Patients Receiving Irinotecan-Based Chemotherapy at Al-Najaf Al-Ashraf. Iraqi Journal of Pharmaceutical Sciences. 28, 2 (Dec. 2019), 24–29. DOI:https://doi.org/10.31351/vol28iss2pp24-29.